Reimbursement

From the Editor-in-Chief: Shiny New Objects Within a Struggling System

August 18th 2021, 3:53pm

"No matter where you go, there you are." Buckaroo Banzai

The Impact of Reinsurance of Gene Therapies on Employer Financial Risk

April 22nd 2021, 12:21pm

Report Documents Grim Current Status and Future of US Hospitals

March 25th 2021, 7:46pm

Survey responses of 320 US hospitals highlight the dire consequences of the COVID-19 pandemic on facilities and point to a future of ongoing financial and staffing challenges.

Contributor: A Practical Path Forward to More Patient-Centered Value Assessment

February 16th 2021, 5:00pm

To ensure that value assessment accounts for patient needs, we need a better understanding of the outcomes that are most important to patients, write authors from COVIA Health Solutions and the University of Washington School of Pharmacy.

Experts Issue Recommendations for Improving Health Care, Costs in 2021

February 1st 2021, 5:10pm

With the ongoing coronavirus disease 2019 pandemic, a rising number of uninsured Americans, and a new Democratic president and Senate majority, 2021 is shaping up to be a dynamic year for health care policy.

Contributor: Implementing Pharmacy-Led Telehealth Strategies to Help Medicare Advantage SNPs Improve Care for Older Adults Amid COVID-19 and Beyond

January 24th 2021, 1:00pm

Pharmacy-led telehealth strategies will position Special Needs Plans (SNPs) for Star Ratings success during the pandemic and for years to come.

Amy Ellis Discusses Choosing Between Multiple Oncology APMs

January 20th 2021, 2:00pm

With so many different oncology alternative payment models (APMs) available, choosing the right ones to participate in might simply mean finding which ones already align with what a practice is doing, said Amy Ellis, chief quality officer at Northwest Medical Specialties.

Payer Implications on Reforms to Price Transparency

January 17th 2021, 6:43pm

Amid recent reforms on price transparency by CMS and the Trump administration, payers' workloads will substantially increase with notable challenges that include having to maintain accurate prices and the impact of exposed negotiated rates.

Multiple Factors Hinder Uptake of Monoclonal Antibody Therapeutics for COVID-19

January 14th 2021, 9:33pm

The US Surgeon General, Vice Admiral Jerome Adams, MD, and other officials urged for greater uptake of FDA-approved treatments for coronavirus disease 2019 (COVID-19) in an effort to slow the surge of cases requiring hospitalization. However, logistic, monetary, and efficacy concerns may have drastically limited the amount of biologic treatments actually administered to patients.

Endocrine Society Calls for Negotiated Insulin Prices in Medicare

January 13th 2021, 9:17pm

The statement is aimed at drug companies, policymakers, pharmacy benefit managers, employers, and others, and calls to attention soaring insulin costs, which were the subject of several Congressional hearings in 2019.